Literature DB >> 26888476

Renal Function Profile in White Kidney Donors: The First 4 Decades.

Hassan N Ibrahim1, Robert N Foley2, Scott A Reule2, Richard Spong2, Aleksandra Kukla2, Naim Issa2, Danielle M Berglund3, Gretchen K Sieger3, Arthur J Matas3.   

Abstract

Previous studies reported the risk of ESRD after kidney donation, but not the renal outcomes that precede ESRD. Here, we estimated the risk of proteinuria, reduced GFR, and ESRD in 3956 white kidney donors, assessed the contribution of postdonation hypertension and diabetes to these outcomes, and developed a risk calculator. After a mean±SD follow-up of 16.6±11.9 years, 215 (6.1%) donors developed proteinuria. Men had a higher risk of proteinuria (hazard ratio [HR], 1.56; 95% confidence interval [95% CI], 1.18 to 2.05; P<0.001) as did those with higher body mass index (HR, 1.10; 95% CI, 1.06 to 1.13; P<0.001). In all, 1410 (36%) donors reached an eGFR<60 ml/min per 1.73 m(2), and 112 (2.8%) donors had either an eGFR<30 ml/min per 1.73 m(2) or ESRD (28 donors developed ESRD). An eGFR<30 ml/min per 1.73 m(2) or ESRD associated with older age (HR, 1.07; 95% CI, 1.05 to 1.09; P<0.001), higher body mass index (HR, 1.08; 95% CI, 1.04 to 1.13; P<0.001), and higher systolic BP (HR, 1.02; 95% CI, 1.00 to 1.04; P=0.01) at donation. Postdonation diabetes and hypertension associated with a fourfold higher risk of proteinuria and a >2-fold higher risk of ESRD. Models predicting proteinuria and reduced eGFR performed well (C-index 0.77-1.00). In conclusion, severe reduction in GFR and ESRD after kidney donation were uncommon and were highly associated with postdonation diabetes and hypertension. Furthermore, information available before donation may predict long-term renal outcomes in white living kidney donors.
Copyright © 2016 by the American Society of Nephrology.

Entities:  

Keywords:  kidney donation; outcomes; renal dysfunction

Mesh:

Year:  2016        PMID: 26888476      PMCID: PMC5004661          DOI: 10.1681/ASN.2015091018

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  16 in total

1.  K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification.

Authors: 
Journal:  Am J Kidney Dis       Date:  2002-02       Impact factor: 8.860

2.  What is the concordance between the medical record and patient self-report as data sources for ambulatory care?

Authors:  Diana M Tisnado; John L Adams; Honghu Liu; Cheryl L Damberg; Wen-Pin Chen; Fang Ashlee Hu; David M Carlisle; Carol M Mangione; Katherine L Kahn
Journal:  Med Care       Date:  2006-02       Impact factor: 2.983

3.  OPTN/SRTR 2013 Annual Data Report: kidney.

Authors:  A J Matas; J M Smith; M A Skeans; B Thompson; S K Gustafson; D E Stewart; W S Cherikh; J L Wainright; G Boyle; J J Snyder; A K Israni; B L Kasiske
Journal:  Am J Transplant       Date:  2015-01       Impact factor: 8.086

4.  Evaluating the yield of medical tests.

Authors:  F E Harrell; R M Califf; D B Pryor; K L Lee; R A Rosati
Journal:  JAMA       Date:  1982-05-14       Impact factor: 56.272

5.  US Renal Data System 2014 Annual Data Report: Epidemiology of Kidney Disease in the United States.

Authors:  Rajiv Saran; Yi Li; Bruce Robinson; John Ayanian; Rajesh Balkrishnan; Jennifer Bragg-Gresham; Joline T L Chen; Elizabeth Cope; Debbie Gipson; Kevin He; William Herman; Michael Heung; Richard A Hirth; Steven S Jacobsen; Kamyar Kalantar-Zadeh; Csaba P Kovesdy; Alan B Leichtman; Yee Lu; Miklos Z Molnar; Hal Morgenstern; Brahmajee Nallamothu; Ann M O'Hare; Ronald Pisoni; Brett Plattner; Friedrich K Port; Panduranga Rao; Connie M Rhee; Douglas E Schaubel; David T Selewski; Vahakn Shahinian; John J Sim; Peter Song; Elani Streja; Manjula Kurella Tamura; Francesca Tentori; Paul W Eggers; Lawrence Y C Agodoa; Kevin C Abbott
Journal:  Am J Kidney Dis       Date:  2015-07       Impact factor: 8.860

6.  Long-term consequences of kidney donation.

Authors:  Hassan N Ibrahim; Robert Foley; LiPing Tan; Tyson Rogers; Robert F Bailey; Hongfei Guo; Cynthia R Gross; Arthur J Matas
Journal:  N Engl J Med       Date:  2009-01-29       Impact factor: 91.245

7.  Familial clustering of ESRD in the Norwegian population.

Authors:  Rannveig Skrunes; Einar Svarstad; Anna Varberg Reisæter; Bjørn Egil Vikse
Journal:  Clin J Am Soc Nephrol       Date:  2014-08-04       Impact factor: 8.237

8.  The unjustified classification of kidney donors as patients with CKD: critique and recommendations.

Authors:  Arthur J Matas; Hassan N Ibrahim
Journal:  Clin J Am Soc Nephrol       Date:  2013-06-27       Impact factor: 8.237

9.  A new equation to estimate glomerular filtration rate.

Authors:  Andrew S Levey; Lesley A Stevens; Christopher H Schmid; Yaping Lucy Zhang; Alejandro F Castro; Harold I Feldman; John W Kusek; Paul Eggers; Frederick Van Lente; Tom Greene; Josef Coresh
Journal:  Ann Intern Med       Date:  2009-05-05       Impact factor: 25.391

10.  Demographic, metabolic, and blood pressure characteristics of living kidney donors spanning five decades.

Authors:  S J Taler; E E Messersmith; A B Leichtman; B W Gillespie; C E Kew; M D Stegall; R M Merion; A J Matas; H N Ibrahim
Journal:  Am J Transplant       Date:  2012-11-08       Impact factor: 8.086

View more
  37 in total

1.  Larger nephron size, low nephron number, and nephrosclerosis on biopsy as predictors of kidney function after donating a kidney.

Authors:  Naim Issa; Lisa E Vaughan; Aleksandar Denic; Walter K Kremers; Harini A Chakkera; Walter D Park; Arthur J Matas; Sandra J Taler; Mark D Stegall; Joshua J Augustine; Andrew D Rule
Journal:  Am J Transplant       Date:  2019-02-01       Impact factor: 8.086

2.  Associations of obesity with antidiabetic medication use after living kidney donation: An analysis of linked national registry and pharmacy fill records.

Authors:  Krista L Lentine; Farrukh M Koraishy; Nagaraju Sarabu; Abhijit S Naik; Ngan N Lam; Amit X Garg; David Axelrod; Zidong Zhang; Gregory P Hess; Bertram L Kasiske; Dorry L Segev; Macey L Henderson; Allan B Massie; Courtenay M Holscher; Mark A Schnitzler
Journal:  Clin Transplant       Date:  2019-09-08       Impact factor: 2.863

3.  Quantifying Postdonation Risk of ESRD in Living Kidney Donors.

Authors:  Allan B Massie; Abimereki D Muzaale; Xun Luo; Eric K H Chow; Jayme E Locke; Anh Q Nguyen; Macey L Henderson; Jon J Snyder; Dorry L Segev
Journal:  J Am Soc Nephrol       Date:  2017-04-27       Impact factor: 10.121

Review 4.  Hyperfiltration-mediated Injury in the Remaining Kidney of a Transplant Donor.

Authors:  Tarak Srivastava; Sundaram Hariharan; Uri S Alon; Ellen T McCarthy; Ram Sharma; Ashraf El-Meanawy; Virginia J Savin; Mukut Sharma
Journal:  Transplantation       Date:  2018-10       Impact factor: 4.939

5.  Application of the 2017 KDIGO Guideline for the Evaluation and Care of Living Kidney Donors to Clinical Practice.

Authors:  Amit X Garg; Andrew S Levey; Bertram L Kasiske; Michael Cheung; Krista L Lentine
Journal:  Clin J Am Soc Nephrol       Date:  2020-04-10       Impact factor: 8.237

6.  Long-Term Living Kidney Donor Risk: A Web-Based Calculator.

Authors:  Elise F Palzer; Shruti Vempati; Erika S Helgeson; Arthur J Matas
Journal:  J Am Soc Nephrol       Date:  2020-10-30       Impact factor: 10.121

7.  Strategies for assessing GFR and albuminuria in the living kidney donor evaluation.

Authors:  Lesley A Inker; Naya Huang; Andrew S Levey
Journal:  Curr Transplant Rep       Date:  2017-01-29

8.  The Change in Living Kidney Donation in Women and Men in the United States (2005-2015): A Population-Based Analysis.

Authors:  Jagbir Gill; Yayuk Joffres; Caren Rose; Julie Lesage; David Landsberg; Matthew Kadatz; John Gill
Journal:  J Am Soc Nephrol       Date:  2018-03-08       Impact factor: 10.121

Review 9.  Risks of Living Kidney Donation: Current State of Knowledge on Outcomes Important to Donors.

Authors:  Krista L Lentine; Ngan N Lam; Dorry L Segev
Journal:  Clin J Am Soc Nephrol       Date:  2019-03-11       Impact factor: 8.237

Review 10.  Apolipoprotein L1 Gene Effects on Kidney Transplantation.

Authors:  Barry I Freedman; Jayme E Locke; Amber M Reeves-Daniel; Bruce A Julian
Journal:  Semin Nephrol       Date:  2017-11       Impact factor: 5.299

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.